Recent studies highlight the value of long reads in methylation sequencing for oncology research, showcasing adaptive sequencing's efficiency in detecting imprinting disorders like PWS & AS. Nanopore's platform offers flexibility with short and long reads, including epigenetic information. Pioneering work enables actionable methylation detection and CNV calling from low pass WGS for tumor type discrimination, reducing barriers in FFPE samples.
PacBio cancer genomics expert @JBibliowicz76 spoke with @Biocompare about the role of long-read sequencing in advancing cancer research. Read the story here👇 https://t.co/wcnJ8h6Dtv
Actionable methylation detection and CNV calling from low pass WGS to enable discrimination of tumor types from 210Mb of data (@nanopore MinION scale). From FFPE sample. One less barrier. Thanks to pioneering work of @thomachr87 et al. https://t.co/2LoHT7oMAo
What you're missing matters. #WYMM Here, Yamada et al. showcase how adaptive sequencing unveils the mysteries of imprinting disorders like PWS & AS. No PCR. No bias. Just direct detection of methylation with groundbreaking efficiency. Read here: https://t.co/3mIuudTgUV https://t.co/v1zEbxHVna
Long Reads Perform Well in ABRF, DeCode Genetics Methylation Sequencing Benchmarking Studies https://t.co/M3U8yNFLDV
Have a read on my new piece on #biomarker discovery in #oncology for #pharma and #biotech in https://t.co/XuoFddR4FX Note the value of @nanopore flexible platform: short and long reads as well epigenetic information included. What you are missing matters!